Fig. 1From: Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysismTOR pathway and inhibition of mTOR through Rapamycin-FKBP12 complexBack to article page